OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

10491	Companies
221179	Keywords
150421	Articles
116986	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 01/13/2025 at 18:00, 1 year 4 months ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converted 4 convertible bonds in Oxurion, leading to a EUR 100,000 capital increase. Oxurion focuses on developing vision-preserving therapeutics for the elderly

Capital Increase Oxurion Atlas Special Opportunities, LLC Innovative Therapeutics Elderly Vision
PRESS RELEASE

published on 01/13/2025 at 18:00, 1 year 4 months ago

Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Atlas Special Opportunities, LLC convertit 4 obligations convertibles en Oxurion pour une augmentation de capital de 100 000 EUR, soutenant le développement de médicaments pour préserver la vision des personnes âgées

Obligations Convertibles Augmentation De Capital Atlas Special Opportunities Médicaments Innovants Oxurion
BRIEF

published on 01/06/2025 at 18:05, 1 year 4 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Transparency Biopharmaceutical Shareholding Atlas Special Opportunities Oxurion
BRIEF

published on 01/06/2025 at 18:05, 1 year 4 months ago

Oxurion reçoit une notification de transparence de la part d'Atlas Special Opportunities LLC

Actionnariat Transparence Biopharmaceutique Oxurion Opportunités Spéciales Atlas
PRESS RELEASE

published on 01/06/2025 at 18:00, 1 year 4 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities, LLC revealing a stake above 15% threshold due to purchase of voting securities

Transparency Notification Biopharmaceutical Atlas Special Opportunities Ophthalmic Therapies Oxurion NV
PRESS RELEASE

published on 01/06/2025 at 18:00, 1 year 4 months ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities LLC regarding ownership of 624,817 shares, exceeding the 15% threshold

Transparency Notification Share Ownership Atlas Special Opportunities LLC Oxurion NV Ophthalmological Therapies
BRIEF

published on 01/03/2025 at 18:05, 1 year 4 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Shares Transparency Biopharmaceutical Atlas Special Opportunities Oxurion
BRIEF

published on 01/03/2025 at 18:05, 1 year 4 months ago

Oxurion reçoit une notification de transparence de la part d'Atlas Special Opportunities LLC

Actions Transparence Biopharmaceutique Oxurion Opportunités Spéciales Atlas
PRESS RELEASE

published on 01/03/2025 at 18:00, 1 year 4 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
Oxurion NV received a transparency notification under Belgian Transparency legislation from Atlas Special Opportunities, LLC, regarding the sale of voting securities

Transparency Notification Atlas Special Opportunities LLC Oxurion NV Belgian Legislation Retinal Disease Therapy
PRESS RELEASE

published on 01/03/2025 at 18:00, 1 year 4 months ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC
Oxurion NV announces receipt of transparency notification regarding shareholding. Bio-pharmaceutical company developing ophthalmological therapies. Refer to website for more details

Transparency Notification Shareholding Belgium Oxurion NV Ophthalmological Therapies

Accesswire

Published on 06/02/2026 at 22:30, 48 minutes ago

INEO Announces Effective Date of Share Consolidation
Published on 06/02/2026 at 22:00, 1 hour 18 minutes ago

NYMOX Provides Current Update
Published on 06/02/2026 at 19:45, 3 hours 33 minutes ago

Announces Plans to Repurchase Common Shares
Published on 06/02/2026 at 19:40, 3 hours 38 minutes ago

Taranis Outlines Four High-Priority Targets Around Thor and Thirty Prospects and Old Mines Located within 6,470 Ha Property
Published on 06/02/2026 at 16:15, 7 hours 3 minutes ago

Vulcan Minerals Inc. - Drilling to Resume at Carbonear Zinc-Lead SEDEX project in Newfoundland

View all ACCESSWIRE

EQS Group

Published on 06/02/2026 at 22:35, 43 minutes ago

Hycroft Delivers $10 Billion NPV from Technical Report at Spot Prices While Advancing High-Grade Brimstone and Vortex Silver Discoveries
Published on 06/02/2026 at 19:50, 3 hours 28 minutes ago

Recorded Future Announces Strategic Partnership with Wipro to Deliver AI-Powered Threat Intelligence at Global Enterprise Scale
Published on 06/02/2026 at 19:41, 3 hours 36 minutes ago

Avolta prices EUR 400 million of Senior Notes
Published on 06/02/2026 at 19:28, 3 hours 50 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/02/2026 at 19:00, 4 hours 18 minutes ago

PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF

Les Echos

Published on 06/02/2026 at 18:03, 5 hours 15 minutes ago

Capital et droits de vote au 31 mai 2026
Published on 06/02/2026 at 18:03, 5 hours 15 minutes ago

Total number of voting rights and shares making up the share capital at May 31, 2026
Published on 06/02/2026 at 17:42, 5 hours 36 minutes ago

Aéroports de Paris SA - Actions et droits de vote au 31 mai 2026
Published on 06/02/2026 at 17:42, 5 hours 36 minutes ago

Aéroports de Paris SA - Shares and voting rights as of 31 May 2026
Published on 06/02/2026 at 17:40, 5 hours 38 minutes ago

Campus AI entre en phase de réalisation : Eiffage retenu pour le déploiement des infrastructures communes du campus de Fouju. Un marché de plus de 120 millions d’euros.

View all LES ECHOS COMFI WIRE